Drs. Brian Layden and Barton Wicksteed recently published in Endocrinology, “Incretin‐Based Therapies: Revisiting Their Mode of Action”, highlighting now an important class of diabetes and obesity drug works.

The full article can be found on the Endocrinology website at https://academic.oup.com/endo/article/158/6/1560/3859567/